Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.
Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what...
Organicell (BPSR) a Triple Since Easter.
Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's.
RELATED: Adding Organicell (BPSR)...
After FDA authorizes at-home saliva test for Covid-19, startups begin selling test kits.
MedCityNews
The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics....
Biotech Stock Review Adds One Medical (ONEM) $28.50 to Watchlist.
It Ain't Cheap at $3.5 Billion.It's Near Doubled Since March 20th.But Look at the Growth.Look at the Cash.Don't Look at the Bottom...
Biotech Stock Review: Mitesco (MITI) $0.03, Report Update
Mitesco to Launch Telehealth Enabled Primary Care Clinic Business with Q4 Rollout Addressing Healthcare Backlog Accentuated by the Second Wave Concerns.
Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double in 2020.
No Doubles Yet, But They're Doing Rather Well, Considering Everything. Our Confidence Remains Unwavered. Best Performer up 63%.
Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus Related Acute Respiratory...
Sumbmits pre-IND Into Coronavirus Treatment Acceleration Program (CTAP).
Citius Announces Pre-IND Submission to FDA Under the Coronavirus...
Immunomedics (IMMU) up 100% Today or $2 Billion in Value.
Again as mentioned a few weeks ago, our bearish market opinion is related to large-caps and large-cap funds and ETF's. If...
European Hand Sanitizer Market Expected to Reach $9.4 Billion by 2027.
Growing at a CAGR of 38.4% during 2019–2027.
The European hand sanitizer market was valued at US$ 641.7 million...
Antibiotic-Resistant Super Gonorrhea (CDC).
"We are currently down to one last recommended and effective class of antibiotics, cephalosporins, to treat this common...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
